CLI tool to initialize a React Native application with Expo. Provides options to include Typescript, file-based routing via Expo Router, configuration based routing via pure React Navigation, styling ...

Lethal injection is 'unreliable, unworkable and unacceptably prone to errors,' commissioner says Hobbs’ office released 12 pages written by Duncan, who described them as an outline of what was ...

On Wednesday, Piper Sandler adjusted its outlook on shares of Arrowhead Pharma (NASDAQ:ARWR), reducing the 12-month price target to $45 from the previous $62 while maintaining an Overweight rating on ...

On Wednesday, Piper Sandler adjusted its outlook on shares of Arrowhead Pharma (NASDAQ:ARWR), reducing the 12-month price target to $45 from the previous $62 while maintaining an Overweight rating ...

Sarepta Therapeutics has turned to dealmaking to restock a drug pipeline analysts worried was growing thin, announcing Tuesday a deal with Arrowhead Pharmaceuticals that will give it four ...

As 2024 draws to a close, many manufacturers opt for more drastic cost-cutting options as they continue investing heavily in EV technology. Major car companies like Detroit's GM, Ford, and ...

Sarep­ta Ther­a­peu­tics and Ar­row­head Phar­ma­ceu­ti­cals teamed up on an siR­NA part­ner­ship that has one of the biggest promis­es of biobucks in re­cent years.

Arrowhead Pharmaceuticals (NASDAQ:ARWR) added ~21% in the premarket on Tuesday after the company announced a global licensing and collaboration agreement with Sarepta Therapeutics (NASDAQ:SRPT ...

Sarepta Therapeutics is paying Arrowhead Pharmaceuticals $500 million in cash, plus a $325 million equity investment, for worldwide licensing rights to seven programs—four clinical and three ...

Sarepta Therapeutics said Tuesday that it will pay Arrowhead Pharmaceuticals $500 million in cash for a series of experimental RNA-based drugs to treat rare diseases in the muscle, nervous system ...